News Column

Findings from Zhejiang University Has Provided New Information about Cancer Gene Therapy

June 16, 2014



By a News Reporter-Staff News Editor at Cancer Gene Therapy Week -- A new study on Biotechnology is now available. According to news reporting originating in Hangzhou, People's Republic of China, by NewsRx journalists, research stated, "Mesenchymal stromal cells (MSCs) in bone marrow may enhance tumor metastases through the secretion of chemokines. MSCs have been reported to home toward the hypoxic tumor microenvironment in vivo."

The news reporters obtained a quote from the research from Zhejiang University, "In this study, we investigated prostate cancer PC3 cell behavior under the influence of hypoxia preconditioned MSCs and explored the related mechanism of prostate cancer lymphatic metastases in mice. Transwell assays revealed that VEGF-C receptor, VEGFR-3, as well as chemokine CCL21 receptor, CC chemokine receptor 7 (CCR7), were responsible for the migration of PC3 cells toward hypoxia preconditioned MSCs. Knock-in Ccr7 in PC3 cells also improved cell migration in vitro. Furthermore, when PC3 cells were labeled using the hrGfp-lentiviral vector, and were combined with hypoxia preconditioned MSCs for xenografting, it resulted in an enhancement of lymph node metastases accompanied by up-regulation of VEGFR-3 and CCR7 in primary tumors. Both PI3K/Akt/I?B? and JAK2/STAT3 signaling pathways were activated in xenografts in the presence of hypoxia-preconditioned MSCs. Unexpectedly, the p-VEGFR-2/VEGFR-2 ratio was attenuated accompanied by decreased JAK1 expression, indicating a switching-off of potential vascular signal within xenografts in the presence of hypoxia-preconditioned MSCs. Unlike results from other studies, VEGF-C maintained a stable expression in both conditions, which indicated that hypoxia preconditioning of MSCs did not influence VEGF-C secretion."

According to the news reporters, the research concluded: "Our results provide the new insights into the functional molecular events and signalings influencing prostate tumor metastases, suggesting a hopeful diagnosis and treatment in new approaches."

For more information on this research see: Hypoxia preconditioning of mesenchymal stromal cells enhances PC3 cell lymphatic metastasis accompanied by VEGFR-3/CCR7 activation. Journal of Cellular Biochemistry, 2013;114(12):2834-41. (Wiley-Blackwell - www.wiley.com/; Journal of Cellular Biochemistry - onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-4644)

Our news correspondents report that additional information may be obtained by contacting X. Huang, Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education, Key Laboratory of Molecular Biology in Medical Science, 2nd Affiliated Hospital, Zhejiang University, Hangzhou, 310009, People's Republic of China. Additional authors for this research include K. Su, L. Zhou, G. Shen, Q. Dong, Y. Lou and S. Zheng (see also Biotechnology).

Keywords for this news article include: Asia, Biotechnology, Hangzhou, Immunology, Stromal Cells, Membrane Proteins, Cytokine Receptors, Cancer Gene Therapy, Chemokine Receptors, Chemotactic Factors, Lymphatic Metastasis, Inflammation Mediators, Connective Tissue Cells, People's Republic of China, G Protein Coupled Receptors.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Cancer Gene Therapy Week


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters